1Department of Pathology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, 230036, China; 2Intelligent Pathology Institute, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, 230036, China; 3Department of Pathology, The First Affiliated Hospital of USTC, Division of life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, 230031, China.
Department of Head And Neck Breast Surgery, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, 230031, China.
Acta Biochim Pol. 2020 Dec 17;67(4):515-519. doi: 10.18388/abp.2020_5371.
The phosphatase and tensin homolog (PTEN) is a tumor suppressor lipid phosphatase frequently mutated or deleted in breast cancer cells. Loss of PTEN is associated with aberrant activation of P13K/AKT signaling pathways, which are responsible for uncontrolled cell cycle, migration and prolonged survival. Therefore, stability and functional PTEN is essential for prevention of cancer growth and migration. In the present study, we have determined the effect of PTEN over expression in apoptosis induction and cell proliferation in breast cancer cells. We showed that PTEN over expression significantly declined the cell proliferation rate during logarithmic growth phase. Furthermore, the PTEN over expression leads to the activation of mitochondrial based intrinsic apoptosis pathways, which is confirmed by the activation and over expression of caspases 9 and caspases 3. In addition, the number of apoptotic cells are significantly more in PTEN over expressed cells, where they showed more apoptotic bodies in AO-EtBr and Hoechst 33344 staining. Finally, PTEN over expressed cells showed decreased chemo resistance as chemotherapeutic drugs kill them efficiently. Therefore, our findings suggest that tumor suppressive effect of PTEN is crucial for cancer prevention and thus PTEN might be a potential target for anti-cancer drugs.
磷酸酶和张力蛋白同源物(PTEN)是一种肿瘤抑制脂质磷酸酶,在乳腺癌细胞中经常发生突变或缺失。PTEN 的缺失与 P13K/AKT 信号通路的异常激活有关,该通路负责失控的细胞周期、迁移和延长的存活。因此,PTEN 的稳定性和功能性对于预防癌症生长和迁移至关重要。在本研究中,我们确定了过表达 PTEN 对乳腺癌细胞凋亡诱导和细胞增殖的影响。我们表明,过表达 PTEN 可显著降低对数生长期的细胞增殖率。此外,PTEN 的过表达导致基于线粒体的内在凋亡途径的激活,这通过激活和过表达 caspase 9 和 caspase 3 得到证实。此外,在过表达 PTEN 的细胞中,凋亡细胞的数量明显更多,在 AO-EtBr 和 Hoechst 33344 染色中显示出更多的凋亡小体。最后,过表达 PTEN 的细胞表现出对化疗药物的耐药性降低,因为化疗药物能有效地杀死它们。因此,我们的研究结果表明,PTEN 的肿瘤抑制作用对于癌症预防至关重要,因此 PTEN 可能是抗癌药物的潜在靶点。